18th Jan 2024 The MOUNTAINEER study: a plain language summary looking at how effective and safe tucatinib plus trastuzumab is for treating people with metastatic colorectal cancer
3rd Nov 2023 A plain language summary of the DESTINY-Gastric01 study: trastuzumab deruxtecan in previously treated HER2-positive gastric cancer